Diakonos Research Ltd.

1110 Nasa Parkway Suite 108i

Houston, TX 77058

©2016 BY DIAKONOS RESEARCH LTD.

In the Clinic

What’s Happening

Diakonos Research, Ltd. is a clinical stage immuno-oncology company that is developing the next generation of cell-based immunotherapy. Dendritic cells are an integral part of the immune system. The Diakonos Dendritic Cell vaccine platform is designed to be a safe and efficacious adjunct therapy for the treatment of cancer and functions by programming the immune system to specifically recognize and target tumor tissue.

CANINE HEMANGIOSARCOMA (HSA) TRIAL

BRAIN CANCER TRIAL

PIPELINE